Chemomab Therapeutics Ltd.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2017 | — | $-609.0K | $1.5M |
| Dec 2018 | — | $9.8M | $7.5M |
| Mar 2019 | — | $31.3M | $32.1M |
| Jun 2019 | — | $27.2M | $27.0M |
| Sep 2019 | — | $20.4M | $23.2M |
| Dec 2019 | — | $12.4M | $17.6M |
| Mar 2020 | — | $10.7M | $14.0M |
| Jun 2020 | — | $12.8M | $8.8M |
| Sep 2020 | — | $12.2M | $6.8M |
| Dec 2020 | — | $10.8M | $11.7M |
| Mar 2021 | — | $55.2M | $58.2M |
| Jun 2021 | — | $68.0M | $45.4M |
| Sep 2021 | — | $65.5M | $37.7M |
| Dec 2021 | — | $61.5M | $15.2M |
| Mar 2022 | — | $57.2M | $13.8M |
| Jun 2022 | — | $51.8M | $9.9M |
| Sep 2022 | — | $44.6M | $10.7M |
| Dec 2022 | — | $36.2M | $13.5M |
| Mar 2023 | — | $28.0M | $20.8M |